Rocket Lab USAの空売り状況は、投資家がRocket Lab USAの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Rocket Lab USA (NASDAQ:RKLB) 株価情報, 空売り情報

ROCKET LAB USA INC

Rocket Lab USA

Rocket Lab USA Inc is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, rest of the world and earns key revenue from the United States.

News

Movers

AMKR

BILI

BRFS

IBRX

IRTC

ITCI

OLLI

RKLB

TALO

これらの中型株は先週最も楽観的なパフォーマンスを示しました。あなたのポートフォリオには入っていますか？Bilibili Inc.は（NASDAQ：BILI）は、先週「三國：謀定天下」の発売以降23.32%上昇しました。さらに、JPモルガン（JP Morgan）のアナリスト、ダニエル・チェン氏はBilibiliの株をニュートラル（中立評価）からオーバーウェイト（買い評価）に格上げし、21ドルの株価予測を発表しました。

中国配信大手ビリビリ　株価が23%の高騰

Rocket Lab USA Inc

Canaccord Genuity analyst Maria Ripps initiates coverage on Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Buy rating and announces Price Target of $12.

Price Target

Initiation

Analyst Ratings

NEXN

Canaccord Genuity Initiates Coverage On Nexxen International with Buy Rating, Announces Price Target of $12

Gold miners dominated <a target="_blank" href="https://www.benzinga.com/topic/mergers-and-acquisitions" rel="noreferrer noopener">mergers and acquisitions (M&amp;A) activity</a> in the metals and mining industry in 2024. Research by S&amp;P Global Market Intelligence found that yellow metal deals accounted for 70% of the total transaction value.
The <a target="_blank" href="https://www.spglobal.com/market-intelligence/en/news-insights/research/mining-mna-in-2024-gold-dominates-mna-space-for-2nd-consecutive-year" rel="noreferrer noopener">report</a> showed 62 gold-related transactions, compared to 47 in 2023, or a 32% growth. Although the overall deal value remained relatively close, at $26.36 billion, the $16.5 billion Newmont's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) acquisition of Newcrest was an outlier, skewing the numbers for the year before.
Most of 2024's M&amp;A occurred in two top jurisdictions, Australia and Canada. Gold's 27% surge in 2024 further incentivized acquisitions, while geopolitical risks, including the persisting conflict in Ukraine, tensions in the Middle East, and rising central bank purchases, encouraged expansions through acquisitions.
Northern Star Resources (OTCPK: NESRF) <a target="_blank" href="https://www.benzinga.com/24/12/42262825/northern-star-acquires-de-grey-for-33-billion-secures-promising-tier-1-asset" rel="noreferrer noopener">$3.26 billion acquisition</a> of De Grey Mining was the largest single transaction, consolidating ownership of one of Australia's most promising gold deposits. The number two spot went to AngloGold Ashanti's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>) <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/09/40790433/anglogold-ashanti-to-acquire-centamin-for-2-5b-to-become-fourth-largest-gold-producer" rel="noreferrer noopener">$2.48 billion takeover</a> of Centamin, strengthening its African presence.
In contrast, despite copper's growing popularity, copper-focused M&amp;A was comparatively subdued, with 16 total deals amounting to $5.7 billion. The largest one was Lundin Mining and BHP's joint <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/40031488/bhp-to-unlock-south-american-copper-riches-partners-with-lundin-for-filo-acquisition" rel="noreferrer noopener">$3.03 billion acquisition</a> of Filo Corp. If BHP's <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/05/39068033/time-runs-out-for-bhp-deal-49-billion-acquisition-of-anglo-american-proves-too-complex-to-solve" rel="noreferrer noopener">$49 billion bid for </a><a target="_blank" href="https://www.benzinga.com/news/large-cap/24/05/39068033/time-runs-out-for-bhp-deal-49-billion-acquisition-of-anglo-american-proves-too-complex-to-solve" rel="noreferrer noopener">Anglo American</a> had succeeded, the situation would have been vastly different.
S&amp;P's report also highlighted that while overall deal value remained stable, the absence of a $10 billion-plus megadeal meant that the average transaction size fell to $428.1 million—the lowest in five years and a 24% decline from 2023.
Large miners like Newmont sold smaller portfolio parts, focusing on top assets. At the same time, intermediate producers sought those assets to pursue margin-boosting synergies and growth necessary to break into the big leagues of producing over 1 million ounces annually.
In 2025, S&amp;P predicts further positive momentum in gold M&amp;A as metal prices bid new highs. The sector has already seen notable activity in early 2025, including Equinox Gold's $1.87 billion bid for Calibre Mining. However, <a target="_blank" href="https://www.benzinga.com/25/03/44394574/the-largest-shareholder-opposes-equinoxs-18-billion-acquisition" rel="noreferrer noopener">opposition from Equinox's top shareholder</a>, Van Eck, raises questions about whether the deal will proceed. Van Eck, who holds significant stakes in both companies, cited a lack of operational synergies as a key concern.
Gold Fields'<a target="_blank" href="https://www.benzinga.com/25/03/44458684/gruyere-power-struggle-gold-fields-surprise-offer-rejected-countermove-denied" rel="noreferrer noopener"> $2.1 billion offer</a> for Gold Road Resources announced this week was rejected as "opportunistic," with Gold Road arguing it undervalued its assets. The deal would have given Gold Fields full control over the Gruyere gold mine, but Gold Road proposed buying out Gold Fields' stake—a counteroffer that was subsequently rejected.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/03/44481208/sandstorm-gold-shares-are-up-today-whats-going-on" target="_blank" rel="noreferrer noopener">Sandstorm Gold Shares Are Up Today: What's Going On?</a></li>
</ul>
Image via Shutterstock

Large Cap

Commodities

Asset Sales

Legal

Markets

GLDM

NESRF

OUNZ

SGOL

Gold M&A Deals Are Accelerating, But Average Deals Are Smaller, Research Shows

Wolfe Research analyst Trevor Allinson downgrades AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) from Outperform to Peer Perform.

Downgrades

AZEK

Wolfe Research Downgrades AZEK Co to Peer Perform

Stifel analyst Annabel Samimy initiates coverage on Palvella Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PVLA#NASDAQ">PVLA</a>) with a Buy rating and announces Price Target of $45.

PVLA

Stifel Initiates Coverage On Palvella Therapeutics with Buy Rating, Announces Price Target of $45

WIIM

OSRH

Osiris Holding shares are trading higher after its subsidiary, Vaximm AG, announced Phase 2a trial results for VXM01 and Avelumab combination therapy in glioblastoma, demonstrating safety and tolerability.

D. Boral Capital analyst Jason Kolbert maintains CervoMed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRVO#NASDAQ">CRVO</a>) with a Buy and maintains $10 price target.

CRVO

D. Boral Capital Maintains Buy on CervoMed, Maintains $10 Price Target

Piper Sandler analyst Charles Neivert downgrades Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) from Overweight to Neutral and lowers the price target from $135 to $120.

Piper Sandler Downgrades Westlake to Neutral, Lowers Price Target to $120

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) with a Buy and maintains $10 price target.

Reiteration

IVVD

HC Wainwright & Co. Reiterates Buy on Invivyd, Maintains $10 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANIX#NASDAQ">ANIX</a>) with a Buy and maintains $10 price target.

ANIX

D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target

Mizuho analyst Gabriel Moreen maintains NiSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NI#NYSE">NI</a>) with a Outperform and raises the price target from $42 to $44.

Mizuho Maintains Outperform on NiSource, Raises Price Target to $44

D. Boral Capital analyst Jesse Sobelson maintains Tetra Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTI#NYSE">TTI</a>) with a Buy and maintains $5.5 price target.

D. Boral Capital Maintains Buy on Tetra Technologies, Maintains $5.5 Price Target

Rosenblatt analyst Chris Brendler maintains Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) with a Buy and maintains $305 price target.

COIN

Rosenblatt Maintains Buy on Coinbase Global, Maintains $305 Price Target

Vaximm Ag, A Subsidiary Of OSRH Holdings, Announced Final Data From The Successful Conclusion Of Its Open-label Phase 2A Clinical Trial Assessing The Safety And Tolerability Of VXM01 In Combination With Avelumab (PD-l1 Inhibitor) In Patients With Recurrent Glioblastoma

Telsey Advisory Group analyst Dana Telsey maintains Guess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) with a Market Perform and lowers the price target from $18 to $13.

Telsey Advisory Group Maintains Market Perform on Guess, Lowers Price Target to $13

Guidance

TBLA

Taboola Says Q1 Results Are Tracking Toward High End Of Guidance Ranges For Revenue, Gross Profit, ex-TAC Gross Profit Ad Adj. EBITDA

QNTM

Quantum Biopharma Announced Its Licensee Celly Nutrition Corporatio Released New Unbuzzd "On-the-go Powder Stick Packs" In An 8-pack Display Box, Facilitating The Sale Of Unbuzzd In Convenience, Liquor, And Drug Stores Across The United States

Phillips 66 Files Preliminary Proxy Statement For 2025 Annual Meeting; Recommends Shareholders Use White Proxy Card And Vote Against Elliott's Proposal

LPTX

Leap Therapeutics shares are trading higher after the company presented updated preliminary data from its Sirexatamab colorectal cancer study.

CCLD

CareCloud Announced The Expanded Adoption Of Its Services By Alpine Ear, Nose & Throat Pc, A Premier Otolaryngology Group Based In Colorado

HUMA

Humacyte shares are trading lower after the company priced a $50 million public offering of 25 million common shares at $2.00 per share.

Press Releases

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Lab USA

ROSEN, A LEADING LAW FIRM, Encourages Rocket Lab USA, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RKLB

Rocket Lab USA, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 28, 2025 to Discuss Your Rights - RKLB

ATTENTION NASDAQ: RKLB INVESTORS: Contact Berger Montague About a Rocket Lab USA Class Action Lawsuit

ROCKET LAB USA, INC. (NASDAQ: RKLB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Rocket Lab USA, Inc. Investors of Upcoming Deadline

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Lab USA

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Lab USA, Inc. of Class Action Lawsuit and Upcoming Deadlines - RKLB

RKLB INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Rocket Lab USA, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rocket Lab USA, Inc.(RKLB) Shareholders

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Quantum Computing, Atkore, Newmont, and Rocket Lab and Encourages Investors to Contact the Firm

Comments

Rocket Lab USA

空売り

Rocket Lab USA (NASDAQ:RKLB) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル